Evidence map›Paper›PMID 39669834›Full record

ArticleCureus2024

A Rare Case of Metachronous Tumor: Recurrent Primary Lung Cancer.

Hassan Edward Bakali, Seda Kahraman, Ayse Gul Ergonul, Dilara Ozyigit Buyuktalanci

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hassan Edward BakaliThoracic Surgery, Ege University Faculty of Medicine, Izmir, TUR.
Seda KahramanThoracic Surgery, Democracy University, Buca Seyfi Demirsoy Teaching and Research Hospital, Izmir, TUR.
Ayse Gul ErgonulThoracic Surgery, Ege University Faculty of Medicine, Izmir, TUR.
Dilara Ozyigit BuyuktalanciPathology: Department of Medical Pathology, Başakşehir Çam ve Sakura City Hospital, Istanbul, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple primary lung cancers (MPLC) are defined as lung cancers that develop at the time of primary lung cancer detection (synchronous) or during the follow-up period (metachronous). The incidence of MPLC is increasing due to the early detection of lesions by widespread screening methods, improved surgical, medical, and radiation treatment options, and increased survival. We present a case of a patient who was operated on in our clinic and diagnosed with primary lung cancer for the third time with different histopathology. Although rare, we wanted to emphasize that the follow-up and treatment planning for MPLCs, whose incidence is increasing, should be a multidisciplinary approach.

Indexed as

copd (chronic obstructive pulmonary disease)metachronous lung tumorsmultiple primary lung cancersynchronous lung tumorsvatswedge resection

Identifiers

PMID39669834
PMCPMC11636670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.